Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Evaluating Two Loading Regimens of Sunitinib Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by National University Hospital, Singapore
Information provided by (Responsible Party):
National University Hospital, Singapore Identifier:
First received: March 3, 2011
Last updated: June 21, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)